We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$4.49B
AUM Growth
+$113M
Cap. Flow
+$75.7M
Cap. Flow %
1.69%
Top 10 Hldgs %
35.01%
Holding
643
New
28
Increased
86
Reduced
146
Closed
38

Top Buys

Rank Stock Value
1
PAYC icon
Paycom
PAYC
+$21.7M
2
META icon
Meta Platforms (Facebook)
META
+$17.5M
3
AMT icon
American Tower
AMT
+$10.6M
4
DHR icon
Danaher
DHR
+$8.77M
5
SBUX icon
Starbucks
SBUX
+$8.06M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$10.4M
2
PX
Praxair Inc
PX
+$8.76M
3
IDXX icon
Idexx Laboratories
IDXX
+$4.94M
4
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$3.42M
5
FISV
Fiserv Inc
FISV
+$2.36M

Sector Composition

Rank Sector Weight
1 Technology 23.07%
2 Healthcare 17.68%
3 Consumer Staples 12.48%
4 Consumer Discretionary 10%
5 Industrials 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBA icon
301
Pembina Pipeline
PBA
$28.4B
$144K ﹤0.01%
4,598
– –
TOWN icon
302
Towne Bank
TOWN
$3.49B
$144K ﹤0.01%
4,320
– –
CMG icon
303
Chipotle Mexican Grill
CMG
$41.3B
$142K ﹤0.01%
18,800
+2,400
+15% +$18.9K
ZTS icon
304
Zoetis
ZTS
$30.4B
$142K ﹤0.01%
2,653
-762
-22% -$38.7K
STKL
305
DELISTED
SunOpta
STKL
$140K ﹤0.01%
19,855
– –
ESRX
306
DELISTED
Express Scripts Holding Company
ESRX
$140K ﹤0.01%
2,040
-3,143
-61% -$225K
DGX icon
307
Quest Diagnostics
DGX
$26.2B
$138K ﹤0.01%
1,500
– –
GSK icon
308
GSK
GSK
$101B
$137K ﹤0.01%
2,843
– –
EPD icon
309
Enterprise Products Partners
EPD
$81.9B
$135K ﹤0.01%
5,000
– –
IWS icon
310
iShares Russell Mid-Cap Value ETF
IWS
$16B
$135K ﹤0.01%
1,675
– –
OMC icon
311
Omnicom Group
OMC
$23.5B
$135K ﹤0.01%
1,583
+33
+2% +$2.77K
EFOR
312
Everforth Inc
EFOR
$1.34B
$132K ﹤0.01%
3,000
– –
MTB icon
313
M&T Bank
MTB
$36.6B
$131K ﹤0.01%
840
– –
POPE
314
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
$131K ﹤0.01%
2,000
– –
CAG icon
315
Conagra Brands
CAG
$7.18B
$125K ﹤0.01%
3,166
-902
-22% -$33.7K
ET icon
316
Energy Transfer Partners
ET
$72.1B
$124K ﹤0.01%
6,400
– –
MTUS icon
317
Metallus
MTUS
$900M
$124K ﹤0.01%
8,000
– –
CP icon
318
Canadian Pacific Kansas City
CP
$81.5B
$115K ﹤0.01%
4,020
– –
TNL icon
319
Travel + Leisure Co
TNL
$4.58B
$115K ﹤0.01%
3,323
– –
BPL
320
DELISTED
Buckeye Partners, L.P.
BPL
$115K ﹤0.01%
1,741
– –
STE icon
321
Steris
STE
$23.1B
$110K ﹤0.01%
1,630
– –
KIM icon
322
Kimco Realty
KIM
$16.2B
$109K ﹤0.01%
4,325
– –
APH icon
323
Amphenol
APH
$210B
$108K ﹤0.01%
6,400
– –
IWP icon
324
iShares Russell Mid-Cap Growth ETF
IWP
$21B
$107K ﹤0.01%
2,200
– –
SHW icon
325
Sherwin-Williams
SHW
$87.4B
$107K ﹤0.01%
1,200
– –
11 12
13
14 15

Similar funds

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Loring Wolcott & Coolidge Fiduciary Advisors held 643 positions worth $4.49B, up 2.6% from $4.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2016 filing shows 28 new, 86 increased, 146 reduced and 38 closed positions. Its largest new stake was Adient: 27,453 shares worth $1.61M. The largest sale was Novo Nordisk, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2016 buy was Adient: 27,453 shares worth $1.61M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Paycom in Q4 2016, an estimated $21.7M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2016 reduction was Novo Nordisk, cutting an estimated $10.4M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Invesco Water Resources ETF in Q4 2016, selling an estimated $148K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 35% of its $4.49B portfolio in Q4 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 28 new positions and closed 38 in Q4 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 2.6% quarter-over-quarter to $4.49B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2016, filed 2 Feb 2017.